Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bronchial Diseases

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Bronchial Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, RC; Bessou, G; Descamps-Latscha, B; Halbwachs-Mecarelli, L; Lenoir, G; Sermet-Gaudelus, I; Witko-Sarsat, V1
Ishii, S; Nagase, T; Ouchi, Y; Shimizu, T; Shindou, H1
Bureau, M; Dry, J; Lefort, J; Vargaftig, BB; Vincent, D1
Lagente, V; Lefort, J; Maridonneau-Parini, I; Randon, J; Russo-Marie, F; Vargaftig, BB1
Benveniste, J1

Other Studies

5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bronchial Diseases

ArticleYear
Priming of blood neutrophils in children with cystic fibrosis: correlation between functional and phenotypic expression of opsonin receptors before and after platelet-activating factor priming.
    The Journal of infectious diseases, 1999, Volume: 179, Issue:1

    Topics: Adolescent; Adult; Bronchial Diseases; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Female; Genotype; Humans; In Vitro Techniques; Infant; Inflammation Mediators; Male; Neutrophils; Phenotype; Platelet Activating Factor; Pseudomonas Infections; Receptors, Immunologic; Staphylococcal Infections

1999
Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway.
    American journal of respiratory and critical care medicine, 2002, Jan-15, Volume: 165, Issue:2

    Topics: Animals; Atropine; Bronchial Diseases; Bronchoconstrictor Agents; Bronchodilator Agents; Disease Models, Animal; Free Radical Scavengers; Methacholine Chloride; Mice; Mice, Transgenic; Muscle, Smooth; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Muscarinic; Respiratory System; Serotonin; Signal Transduction

2002
Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig.
    Agents and actions, 1991, Volume: 34, Issue:1-2

    Topics: Animals; Aspirin; Azepines; Bronchial Diseases; Bronchoalveolar Lavage Fluid; Escherichia coli; Guinea Pigs; Lipopolysaccharides; Macrophages; Male; Neutrophils; Platelet Activating Factor; Pulmonary Edema; Pyrilamine; Respiratory Hypersensitivity; Triazoles

1991
Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig.
    Biochemical and biophysical research communications, 1985, Aug-30, Volume: 131, Issue:1

    Topics: Aerosols; Animals; Bronchial Diseases; Constriction, Pathologic; Drug Tolerance; Guinea Pigs; Kinetics; Macrophage Activation; Macrophages; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Pulmonary Alveoli; Superoxides

1985
A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity?
    The American review of respiratory disease, 1987, Volume: 135, Issue:6 Pt 2

    Topics: Animals; Bronchial Diseases; Chemical Phenomena; Chemistry; Humans; Muscle Contraction; Platelet Activating Factor; Platelet Aggregation; Respiratory Hypersensitivity

1987